Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.
The Los Angeles County Department of Public Health, through its Substance Abuse Prevention and Control (SAPC) Bureau, announced a new partnership with End Overdose, an organization dedicated to ...
CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in the San Francisco Bay Area, was established as an independent entity in 2024 after licensing ivaltinostat ...
Bell Let's Talk Day 2025 put a spotlight on the youth mental health crisis and six mental health organizations working to address the crisis $1,605,770 contributed to youth ...
EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological malignancies, is presenting clinical data from a ...
Hernando Giraldo MD, Inc.has filed a motion for injunctive relief against Humana Inc., exposing a series of alleged unethical practices that jeopardize patient care and community ...